tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Germany Market
Advertisement

Ryvu Therapeutics SA (9Y4) Income Statement

Compare
1 Followers

Ryvu Therapeutics SA Income Statement

Last quarter (Q1 2025), Ryvu Therapeutics SA's total revenue was zł16.93M, a decrease of -21.63% from the same quarter last year. In Q1, Ryvu Therapeutics SA's net income was zł-25.28M. See Ryvu Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
zł 77.97Mzł 46.86Mzł 38.80Mzł 11.19Mzł 15.41M
Gross Profit
zł 58.39Mzł 29.31Mzł 21.40Mzł -2.54Mzł 6.65M
Operating Expenses
zł 180.49Mzł 130.25Mzł 93.07Mzł 75.98Mzł 42.56M
Depreciation and Amortization
zł 10.50Mzł 10.97Mzł 12.90Mzł 12.56Mzł 12.36M
EBITDA
zł -96.83Mzł -81.04Mzł -65.21Mzł -65.96Mzł -17.87M
Operating Income
zł -122.10Mzł -100.95Mzł -71.67Mzł -77.87Mzł -35.91M
Other Income/Expenses
zł 10.96Mzł 8.84Mzł -773.00Kzł -363.00Kzł 5.08M
Pretax Income
zł -111.14Mzł -92.11Mzł -79.19Mzł -77.42Mzł -30.62M
Net Income
zł -111.44Mzł -92.11Mzł -83.78Mzł -77.53Mzł -31.69M
Per Share Metrics
Basic EPS
zł -4.82zł -4.02zł -4.57zł -4.22zł -1.89
Diluted EPS
zł -4.82zł -4.02zł -4.57zł -4.22zł -1.89
Weighted Average Shares Outstanding
23.12M 22.90M 18.33M 18.36M 16.77M
Weighted Average Shares Outstanding (Diluted)
23.12M 22.90M 18.33M 18.36M 16.77M
Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis